50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 6/10
Monitoring for AI engine activity
In the Engagemii AEO index
#28,213 of 455,790 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Patient Website just got measured.
6/10 means HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Patient Website is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
HEMGENIX is the first-ever FDA-approved gene therapy for hemophilia B. It is a one-time infusion that offers elevated factor IX levels for years.
Industry: Healthcare
gthemophiliab.com1
Structured Data
8
Content Structure
7
Entity Clarity
5
E-E-A-T Signals
6
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Patient Website.
Scored by Engagemii on July 11, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/gthemophiliab
Cite this score: Engagemii (2026). "AEO Score for HEMGENIX® (etranacogene dezaparvovec-drlb) | Official Patient Website." Retrieved from https://engagemii.com/aeo/brands/gthemophiliab
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform